주입 펌프 시장 : 규모, 점유율, 성장률, 산업 분석, 유형별, 용도별, 지역별 고찰, 예측(2026-2034년)

Growth Factors of infusion pump Market

The global infusion pump market was valued at USD 12.78 billion in 2025 and is projected to grow to USD 13.72 billion in 2026, reaching USD 24.49 billion by 2034, exhibiting a CAGR of 7.51% during 2026-2034. The market is witnessing strong growth due to the rising demand for accurate drug delivery systems and increasing prevalence of chronic diseases worldwide.

Infusion pumps are advanced medical devices used to deliver fluids such as nutrients, medications, and insulin into a patient's body in controlled amounts. These devices are widely used in hospitals, clinics, and home care settings due to their precision and ability to improve treatment outcomes.

Market Trends

One of the key trends shaping the market is the growing development of smart infusion pumps and home-based infusion systems. Manufacturers are increasingly integrating advanced technologies such as wireless connectivity, real-time monitoring, and electronic health record (EHR) integration.

The demand for home healthcare has surged significantly, especially after the COVID-19 pandemic. Patients prefer receiving long-term treatments such as chemotherapy, diabetes management, and pain therapy at home, which has boosted innovation in portable and user-friendly infusion devices.

Market Growth Factors

Rising Prevalence of Chronic Diseases

The increasing number of patients suffering from chronic diseases such as diabetes, cancer, and neurological disorders is a major factor driving market growth. Infusion pumps allow precise and continuous drug delivery, which is essential for managing such conditions effectively.

For instance, insulin pumps are gaining popularity among diabetic patients as they provide controlled insulin delivery, improving patient convenience and treatment efficiency.

Growing Demand for Ambulatory Pumps

Ambulatory infusion pumps are portable and allow patients to maintain mobility during treatment. These devices are widely used in both hospital and home settings, particularly for long-term therapies. The shift toward cost-effective treatment solutions and reduced hospital stays is further accelerating their adoption.

Restraining Factors

Despite strong growth, the market faces challenges such as stringent regulatory requirements and product recalls. Regulatory approvals for infusion pumps are complex and time-consuming, which delays product launches.

Additionally, product malfunctions and software errors have led to recalls in recent years, impacting manufacturer credibility and slowing market growth.

Market Segmentation Analysis

By Type

Based on type, the market includes volumetric pumps, syringe pumps, insulin pumps, enteral feeding pumps, elastomeric pumps, implantable pumps, and PCA pumps. Among these, the insulin pump segment dominates the market and is expected to maintain its leadership due to the rising global diabetic population. The segment is projected to account for 26.04% market share in 2026.

By Application

By application, the market is segmented into diabetes, oncology, pain management, and others. The diabetes segment holds the largest share, driven by the increasing number of diabetic patients worldwide and the growing adoption of insulin delivery devices.

By End User

Based on end users, the market includes hospitals, ambulatory care settings, specialty clinics, and home care settings. The hospitals segment dominates, accounting for 54.97% share in 2026, due to high patient inflow and availability of advanced healthcare infrastructure. However, the home care segment is expected to grow at the fastest rate.

Regional Insights

North America

North America dominated the market with a 38.26% share in 2025, valued at USD 4.89 billion, and is projected to reach USD 5.23 billion in 2026. Growth is driven by advanced healthcare infrastructure, high adoption of smart pumps, and favorable reimbursement policies.

Europe

Europe accounted for USD 3.57 billion in 2025 and is expected to reach USD 3.82 billion in 2026. Increasing healthcare expenditure and rising chronic disease burden are supporting market growth in this region.

Asia Pacific

Asia Pacific is emerging as a high-growth region, with market size reaching USD 2.62 billion in 2025 and projected to grow to USD 2.84 billion in 2026. Rapid healthcare infrastructure development and increasing patient awareness are driving demand.

Latin America and Middle East & Africa

These regions are witnessing gradual growth due to improving healthcare systems and rising adoption of advanced medical devices.

Key Companies

Leading players in the infusion pump market include Medtronic, Becton Dickinson and Company, Baxter, Insulet Corporation, and B. Braun Melsungen AG. These companies focus on product innovation, strategic partnerships, and geographic expansion to strengthen their market position.

Conclusion

In conclusion, the infusion pump market is poised for strong growth from USD 12.78 billion in 2025 to USD 24.49 billion by 2034. The increasing prevalence of chronic diseases, advancements in smart medical technologies, and rising demand for home healthcare solutions are key factors driving the market. While regulatory challenges and product recalls may hinder growth, continuous innovation and expanding healthcare access in emerging regions will create significant opportunities. Overall, the market is expected to witness sustained expansion with a strong focus on precision, safety, and patient-centric solutions.

Growth Rate CAGR of 7.51% from 2026-2034

Segmentation By Type

• Volumetric Pumps
• Syringe Pumps
• Elastomeric Pumps
• Insulin Pumps
• Enteral Pumps
• Implantable Pumps
• Patient Control Analgesia (PCA) Pumps

By Application

• Diabetes
• Oncology
• Pain Management
• Others

By End User

• Hospitals
• Ambulatory Care Settings
• Specialty Clinics
• Home Care Settings

By Geography

• North America (By Type, By Application, By End User, and By Country)
  • U.S. (By Type)
  • Canada (By Type)
• Europe (By Type, By Application, By End User, and By Country/Sub-region)
  • Germany (By Type)
  • France (By Type)
  • U.K. (By Type)
  • Italy (By Type)
  • Spain (By Type)
  • Scandinavia (By Type)
  • Rest of Europe (By Type)
• Asia Pacific (By Type, By Application, By End User, and By Country/Sub-region)
  • China (By Type)
  • Japan (By Type)
  • India (By Type)
  • Australia (By Type)
  • Southeast Asia (By Type)
  • Rest of Asia Pacific (By Type)
• Latin America (By Type, By Application, By End User, and By Country/Sub-region)
  • Brazil (By Type)
  • Mexico (By Type)
  • Rest of Latin America (By Type)
• Middle East & Africa (By Type, By Application, By End User, and By Country/Sub-region)
  • GCC (By Type)
  • South Africa (By Type)
  • Rest of Middle East & Africa (By Type)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Chronic Disorders (Diabetes, Cancer, Neurological Disorders, etc.), 2025
• 4.2. Key Industry Developments - Mergers, Acquisitions, and Partnerships
• 4.3. New Product Launches, By Key Players
• 4.4. Technological Advancements in Infusion Pumps
• 4.5. Regulatory Scenario, By Key Countries/Region
• 4.6. Impact of COVID-19 on the Global Infusion Pumps Market

5. Global Infusion Pumps Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Volumetric Pumps
  • 5.1.2. Syringe Pumps
  • 5.1.3. Elastomeric Pumps
  • 5.1.4. Insulin Pumps
  • 5.1.5. Enteral Pumps
  • 5.1.6. Implantable Pumps
  • 5.1.7. Patient Control Analgesia (PCA) Pumps
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. Diabetes
  • 5.2.2. Oncology
  • 5.2.3. Pain Management
  • 5.2.4. Others
• 5.3. Market Analysis, Insights and Forecast - By End User
  • 5.3.1. Hospitals
  • 5.3.2. Ambulatory Care Settings
  • 5.3.3. Specialty Clinics
  • 5.3.4. Home Care Settings
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Infusion Pumps Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Volumetric Pumps
  • 6.1.2. Syringe Pumps
  • 6.1.3. Elastomeric Pumps
  • 6.1.4. Insulin Pumps
  • 6.1.5. Enteral Pumps
  • 6.1.6. Implantable Pumps
  • 6.1.7. Patient Control Analgesia (PCA) Pumps
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Diabetes
  • 6.2.2. Oncology
  • 6.2.3. Pain Management
  • 6.2.4. Others
• 6.3. Market Analysis, Insights and Forecast - By End User
  • 6.3.1. Hospitals
  • 6.3.2. Ambulatory Care Settings
  • 6.3.3. Specialty Clinics
  • 6.3.4. Home Care Settings
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
    • 6.4.1.1. By Type
  • 6.4.2. Canada
    • 6.4.2.1. By Type

7. Europe Infusion Pumps Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Volumetric Pumps
  • 7.1.2. Syringe Pumps
  • 7.1.3. Elastomeric Pumps
  • 7.1.4. Insulin Pumps
  • 7.1.5. Enteral Pumps
  • 7.1.6. Implantable Pumps
  • 7.1.7. Patient Control Analgesia (PCA) Pumps
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Diabetes
  • 7.2.2. Oncology
  • 7.2.3. Pain Management
  • 7.2.4. Others
• 7.3. Market Analysis, Insights and Forecast - By End User
  • 7.3.1. Hospitals
  • 7.3.2. Ambulatory Care Settings
  • 7.3.3. Specialty Clinics
  • 7.3.4. Home Care Settings
• 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.4.1. Germany
    • 7.4.1.1. By Type
  • 7.4.2. France
    • 7.4.2.1. By Type
  • 7.4.3. U.K.
    • 7.4.3.1. By Type
  • 7.4.4. Italy
    • 7.4.4.1. By Type
  • 7.4.5. Spain
    • 7.4.5.1. By Type
  • 7.4.6. Scandinavia
    • 7.4.6.1. By Type
  • 7.4.7. Rest of Europe
    • 7.4.7.1. By Type

8. Asia Pacific Infusion Pumps Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Volumetric Pumps
  • 8.1.2. Syringe Pumps
  • 8.1.3. Elastomeric Pumps
  • 8.1.4. Insulin Pumps
  • 8.1.5. Enteral Pumps
  • 8.1.6. Implantable Pumps
  • 8.1.7. Patient Control Analgesia (PCA) Pumps
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Diabetes
  • 8.2.2. Oncology
  • 8.2.3. Pain Management
  • 8.2.4. Others
• 8.3. Market Analysis, Insights and Forecast - By End User
  • 8.3.1. Hospitals
  • 8.3.2. Ambulatory Care Settings
  • 8.3.3. Specialty Clinics
  • 8.3.4. Home Care Settings
• 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.4.1. China
    • 8.4.1.1. By Type
  • 8.4.2. Japan
    • 8.4.2.1. By Type
  • 8.4.3. India
    • 8.4.3.1. By Type
  • 8.4.4. Australia
    • 8.4.4.1. By Type
  • 8.4.5. South East Asia
    • 8.4.5.1. By Type
  • 8.4.6. Rest of Asia-Pacific
    • 8.4.6.1. By Type

9. Latin America Infusion Pumps Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Volumetric Pumps
  • 9.1.2. Syringe Pumps
  • 9.1.3. Elastomeric Pumps
  • 9.1.4. Insulin Pumps
  • 9.1.5. Enteral Pumps
  • 9.1.6. Implantable Pumps
  • 9.1.7. Patient Control Analgesia (PCA) Pumps
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Diabetes
  • 9.2.2. Oncology
  • 9.2.3. Pain Management
  • 9.2.4. Others
• 9.3. Market Analysis, Insights and Forecast - By End User
  • 9.3.1. Hospitals
  • 9.3.2. Ambulatory Care Settings
  • 9.3.3. Specialty Clinics
  • 9.3.4. Home Care Settings
• 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.4.1. Brazil
    • 9.4.1.1. By Type
  • 9.4.2. Mexico
    • 9.4.2.1. By Type
  • 9.4.3. Rest of Latin America
    • 9.4.3.1. By Type

10. Middle East & Africa Infusion Pumps Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Volumetric Pumps
  • 10.1.2. Syringe Pumps
  • 10.1.3. Elastomeric Pumps
  • 10.1.4. Insulin Pumps
  • 10.1.5. Enteral Pumps
  • 10.1.6. Implantable Pumps
  • 10.1.7. Patient Control Analgesia (PCA) Pumps
• 10.2. Market Analysis, Insights and Forecast - By Application
  • 10.2.1. Diabetes
  • 10.2.2. Oncology
  • 10.2.3. Pain Management
  • 10.2.4. Others
• 10.3. Market Analysis, Insights and Forecast - By End User
  • 10.3.1. Hospitals
  • 10.3.2. Ambulatory Care Settings
  • 10.3.3. Specialty Clinics
  • 10.3.4. Home Care Settings
• 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.4.1. GCC Countries
    • 10.4.1.1. By Type
  • 10.4.2. South Africa
    • 10.4.2.1. By Type
  • 10.4.3. Rest of Middle East & Africa
    • 10.4.3.1. By Type

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Medtronic.
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & Services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Baxter
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & Services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. B. Braun Melsungen AG
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & Services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. BD
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & Services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Fresenius Kabi
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & Services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Tandem Diabetes Care, Inc.
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & Services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. ICU Medical, Inc.
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & Services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Titan Corporation Pvt Ltd
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & Services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. Smiths Group Plc.
    • 11.2.9.1. Overview
    • 11.2.9.2. Products & Services
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)